Search results
Showing 331 to 345 of 390 results for ultrasound
MRI-guided focused ultrasound subthalamotomy for treating Parkinson's (IPG797)
We have moved interventional procedures guidance 797 to become HealthTech guidance 734. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
MRI-based technologies for assessing non-alcoholic fatty liver disease (HTG655)
Evidence-based recommendations on MRI-based technologies for assessing non-alcoholic fatty liver disease.
High-throughput non-invasive prenatal testing for fetal RHD genotype (HTG420)
Evidence-based recommendations on high-throughput non-invasive prenatal testing (NIPT) for fetal RHD genotype.
KODEX-EPD for cardiac imaging during ablation of arrhythmias (MIB260)
NICE has developed a medtech innovation briefing (MIB) on KODEX-EPD for cardiac imaging during ablation of arrhythmias .
This guideline covers managing spasticity and co-existing motor disorders and their early musculoskeletal complications in children and young people (from birth up to their 19th birthday) with non-progressive brain disorders. It aims to reduce variation in practice and help healthcare professionals to select and use appropriate treatments.
Endobronchial ultrasound-guided transbronchial biopsy for peripheral lung lesions (IPG337)
Interventional procedures, IPG337 - Issued: March 2010 --> We have moved interventional procedures guidance 337 to become HealthTech guidance 214. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal masses (IPG254)
Interventional procedures, IPG254 - Issued: February 2008 --> We have moved interventional procedures guidance 254 to become HealthTech guidance 163. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules (IPG562)
We have moved interventional procedures guidance 562 to become HealthTech guidance 416. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Transcranial MRI-guided focused ultrasound thalamotomy for neuropathic pain (IPG632)
We have moved interventional procedures guidance 632 to become HealthTech guidance 491. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids (IPG689)
We have moved interventional procedures guidance 689 to become HealthTech guidance 572. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
High-intensity focused ultrasound for symptomatic benign thyroid nodules (IPG643)
We have moved interventional procedures guidance 643 to become HealthTech guidance 504. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
AmnioSense for unexplained vaginal wetness in pregnancy (MIB198)
NICE has developed a medtech innovation briefing (MIB) on AmnioSense for unexplained vaginal wetness in pregnancy .
Savings are based on a reduction in waiting times for an abortion, ultrasounds and women having rhesus status testing and anti-D...
Talimogene laherparepvec for treating unresectable metastatic melanoma (TA410)
Evidence-based recommendations on talimogene laherparepvec (Imlygic) for treating unresectable metastatic melanoma in adults when systemically administered immunotherapies are not suitable.
Evidence-based recommendations on the Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain.